Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
5.61
+0.18 (3.31%)
Jun 12, 2026, 4:00 PM EDT - Market closed

IMDX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
181215422138200
Market Cap Growth
94.35%417.89%101.13%-45.77%-80.97%21.16%
Enterprise Value
156205.2335.2718.5525.69171.15
Last Close Price
5.617.502.382.506.4243.40
PS Ratio
92.9453.0522.0813.7439.7591.06
PB Ratio
--6.84-3.381.011.113.07
EV/Sales Ratio
80.0450.6118.7512.3426.8277.87
Debt / Equity Ratio
-0.12-0.05-0.190.090.070.07
Net Debt / Equity Ratio
2.350.260.41-0.32-0.49-0.43
Net Debt / EBITDA Ratio
0.540.170.080.281.320.57
Net Debt / FCF Ratio
0.920.320.230.280.340.74
Asset Turnover
0.060.130.030.020.010.02
Inventory Turnover
2.294.115.57---
Quick Ratio
2.361.051.411.381.852.50
Current Ratio
2.541.271.621.492.112.77
Return on Equity (ROE)
226.98%229.65%-910.86%-85.23%-139.11%-129.88%
Return on Assets (ROA)
-147.28%-168.07%-111.01%-28.73%-13.86%-45.18%
Return on Invested Capital (ROIC)
-397.60%-272.44%-132.61%-34.77%-17.87%-56.12%
Return on Capital Employed (ROCE)
-231.52%-246.46%-127.83%-32.29%-15.42%-56.00%
Buyback Yield / Dilution
-87.52%-133.16%-70.84%-38.10%-24.61%-35.80%
Total Shareholder Return
-87.52%-133.16%-70.84%-38.10%-24.61%-35.80%
SEC Filings: 10-K · 10-Q